Reports how new mouse studies map opposing GIPR drug effects to distinct brain regions and outline circuit-based combination strategies.
Key Takeaways
- Neuroscience News More than a billion people worldwide are living with obesity
- New generation of weight loss drugs has emerged that target particular receptors in the brain
- One group of mice lacked GIPR in the brainstem – the area at the base of the brain